H. T. Balli Et Al. , "Reduction of Hepatopulmonary and Intrahepatic Shunts after Treatment with Sorafenib in Hepatocellular Carcinoma Patients," CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY , vol.1, no.1, pp.1-4, 2022
Balli, H. T. Et Al. 2022. Reduction of Hepatopulmonary and Intrahepatic Shunts after Treatment with Sorafenib in Hepatocellular Carcinoma Patients. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY , vol.1, no.1 , 1-4.
Balli, H. T., Aikimbaev, K., Güney, İ. B., Pehlivan, U. A., Piskin, F. C., & Sozutok, S., (2022). Reduction of Hepatopulmonary and Intrahepatic Shunts after Treatment with Sorafenib in Hepatocellular Carcinoma Patients. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY , vol.1, no.1, 1-4.
Balli, Huseyin Et Al. "Reduction of Hepatopulmonary and Intrahepatic Shunts after Treatment with Sorafenib in Hepatocellular Carcinoma Patients," CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY , vol.1, no.1, 1-4, 2022
Balli, Huseyin T. Et Al. "Reduction of Hepatopulmonary and Intrahepatic Shunts after Treatment with Sorafenib in Hepatocellular Carcinoma Patients." CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY , vol.1, no.1, pp.1-4, 2022
Balli, H. T. Et Al. (2022) . "Reduction of Hepatopulmonary and Intrahepatic Shunts after Treatment with Sorafenib in Hepatocellular Carcinoma Patients." CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY , vol.1, no.1, pp.1-4.
@article{article, author={Huseyin Tugsan Balli Et Al. }, title={Reduction of Hepatopulmonary and Intrahepatic Shunts after Treatment with Sorafenib in Hepatocellular Carcinoma Patients}, journal={CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY}, year=2022, pages={1-4} }